Drug Information

Drug General Information
Drug ID
D0I5ZM
Former ID
DIB009235
Drug Name
Remogli ozin-etabonate
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 2 [550338]
Company
Bhv pharma
Target and Pathway
Target(s) Sodium/glucose cotransporter 2 Target Info Modulator [532334]
Reactome Hexose transport
Na+-dependent glucose transporters
Inositol transporters
WikiPathways NRF2 pathway
References
Ref 550338Clinical pipeline report, company report or official report of Bhv pharma.
Ref 532334Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus. BMC Pharmacol Toxicol.2013 Apr 30;14:25.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.